Supplement: TX SB2212 | 2023-2024 | 88th Legislature | Fiscal Note (Introduced)

For additional supplements on Texas SB2212 please see the Bill Drafting List
Bill Title: Relating to the disclosure by a pharmacy to a patient of certain price information for a drug or biological product.

Status: 2023-05-06 - Referred to Public Health [SB2212 Detail]

Download: Texas-2023-SB2212-Fiscal_Note_Introduced_.html
LEGISLATIVE BUDGET BOARD
Austin, Texas
 
FISCAL NOTE, 88TH LEGISLATIVE REGULAR SESSION
 
April 11, 2023

TO:
Honorable Lois W. Kolkhorst, Chair, Senate Committee on Health & Human Services
 
FROM:
Jerry McGinty, Director, Legislative Budget Board
 
IN RE:
SB2212 by Blanco (Relating to the disclosure by a pharmacy to a patient of certain price information for a drug or biological product.), As Introduced

No significant fiscal implication to the State is anticipated.

Based on the analysis of the Board of Pharmacy, duties and responsibilities associated with implementing the provisions of the bill could be accomplished by utilizing existing resources.

Local Government Impact

No significant fiscal implication to units of local government is anticipated.


Source Agencies:
515 Board of Pharmacy
LBB Staff:
JMc, NPe, SLee
feedback